AMETEK delivered a strong finish to 2025 with record fourth quarter sales of $2.0 billion, up 13% year-over-year, and record diluted EPS of $2.01, which exceeded guidance. For the full year, sales reached $7.4 billion (up 7%) with EPS of $7.43 (up 9%), driven by robust core margin expansion of 80 basis points and a record backlog of $3.58 billion. The company demonstrated excellent operational leverage, with Q4 core margins hitting 27.6% (up 100 bps) and free cash flow conversion remaining exceptionally strong at 113% for the year. Looking ahead to 2026, management provided guidance for sales growth in the high single digits and EPS between $7.87 and $8.07, underpinned by a record backlog, strong cash generation, and a disciplined M&A strategy, despite navigating sluggish industrial markets and integration costs from recent acquisitions like FARO.
| Metric | Value | Change |
|---|---|---|
| Q4 Sales | $2.0 billion | +13% year-over-year |
| Q4 Organic Sales Growth | 5% | Up from prior quarters |
| Q4 Diluted EPS | $2.01 | +7% year-over-year (+11% adjusted) |
| Q4 Core Operating Margin | 27.6% | +100 basis points year-over-year |
| Full Year 2025 Sales | $7.4 billion | +7% year-over-year |
| Full Year 2025 EPS | $7.43 | +9% year-over-year |
| Q4 Free Cash Flow | $527 million | +6% year-over-year (132% conversion) |
| Backlog | $3.58 billion | Record high |
| Vitality Index | 30% | Outstanding/Record level |
AMETEK is actively leveraging its strong balance sheet to pursue strategic acquisitions, announcing the purchase of LKC Technologies to expand its med-tech portfolio. Management emphasized a robust M&A pipeline with 'larger deals' than usual, signaling a shift toward more transformative, yet still disciplined, acquisitions. With the capacity to deploy over $5 billion while maintaining an investment-grade rating, AMETEK intends to differentiate performance through acquisitions like FARO and LKC, which offer immediate technology expansion and long-term margin enhancement potential.
Operational excellence and margin expansion remain a core strategic pillar, evidenced by a 100-basis point increase in Q4 core margins to 27.6% and an 80-basis point increase for the full year. The company attributes this to strong incremental margins and the 'AMETEK Growth Model,' which they are successfully integrating into recent acquisitions like Ferro Technologies and Kern Micro Technique. This focus on operational efficiency allows them to absorb lower-margin acquisitions (like FARO at ~15% EBITDA) while still growing overall corporate margins.
The company is experiencing significant growth in its Power and Aerospace & Defense (A&D) end markets, which are serving as key offsets to sluggishness in general industrial sectors. A&D delivered low double-digit growth, driven by European defense spending and commercial aerospace recovery, while the Power segment is benefiting from global grid modernization and the data center build-out. Management specifically highlighted 'ruggedized high-performance solutions' and 'power generation systems for UAV platforms' as areas of strong content wins.
Innovation is driving organic growth, with the company reporting a 'vitality index' of 30%, indicating that 30% of sales come from products introduced in the last three years. Specific product launches like the SpectroMax and XSort are capitalizing on rising commodity prices to drive demand for metals analysis. This high rate of new product introduction supports management's confidence in achieving positive price/cost spreads and sustaining organic growth even in a challenging macro environment.
The Electronic Instruments Group (EIG) showed signs of weakness, with organic sales growing only 2% in Q4, significantly lagging the Electromechanical Group (EMG). Management noted that the Process business within EIG only turned positive in Q4 after negative growth earlier in the year. The guidance for 2026 implies continued sluggishness in this segment, with organic growth expected to be only 'low to mid single digits,' suggesting a delayed recovery in the broader industrial and semiconductor capital expenditure cycles.
The FARO acquisition is currently a drag on profitability, with management acknowledging it runs at mid-teens EBITDA margins compared to AMETEK's corporate average of over 30%. The company recorded $17.6 million in restructuring charges related to the integration. While management is confident in doubling these margins over time, the immediate dilution and the complexity of integrating a lower-margin public company pose execution risks and could suppress reported margin expansion in the near term.
Management's 2026 guidance appears conservative relative to Q4 performance, particularly regarding organic sales growth. Despite Q4 organic orders growing 7% and sales momentum building, the full-year 2026 guide calls for organic sales growth of only 'low to mid-single digits.' This discrepancy suggests management sees risks that could derail the current momentum, such as the potential for a 'short cycle recovery that never happened' to repeat or the impact of 'ongoing macroeconomic uncertainty.'
Exposure to the Chinese market remains a watch area, despite a return to growth in Q4 (up low double digits). Management described the market as having 'real estate hangover' and 'deflation,' noting that their positive performance relies on specific niches like high-value manufacturing and EV testing. A broader slowdown in China or increased geopolitical tensions could impact the 10% sales contribution from Asia, particularly if the 'industrial renaissance' in the West fails to offset Eastern weakness.
Overall: Management exhibited a high level of confidence and satisfaction regarding the company's execution, frequently using superlatives like 'excellent,' 'outstanding,' and 'record' to describe performance. While acknowledging macroeconomic uncertainties and sluggish industrial markets, their demeanor was assured, emphasizing the strength of AMETEK's diversified portfolio and its ability to navigate challenges. The tone shifted to prudent optimism when discussing 2026 guidance, balancing clear momentum with conservative forecasting.
Confidence: HIGH - Management's confidence was evidenced by their specific language on pricing power ('pricing is not going backwards'), the ability to offset inflation/tariffs, and the excitement surrounding the M&A pipeline. They provided detailed metrics to support their success (e.g., 30% vitality index, 100 bps margin expansion) and did not shy away from discussing integration challenges, framing them as calculated opportunities for value creation.
Management expects overall sales to increase by high single digits on a percentage basis. Organic sales are anticipated to grow low to mid-single digits. This implies a contribution from acquisitions of approximately 3-4 percentage points.
Diluted earnings per share are expected to be in the range of $7.87 to $8.07, representing an increase of 6% to 9% compared to 2025 results of $7.43.
For the first quarter, overall sales are anticipated to be up approximately 10% versus the prior year. Adjusted earnings are expected to be $1.90 to $1.95 per share, up 6% to 9% year-over-year.
Free cash flow conversion is expected to be between 110% and 115% of net income, consistent with the strong conversion seen in 2025.
The effective tax rate is anticipated to be between 18.5% and 19.5%.
Hedging & Uncertainty: Management employed a mix of confident assertions and prudent qualifiers. While they used strong definitive language regarding past performance ('records were established,' 'excellent results'), they shifted to more temporal and probabilistic hedges when discussing the future. Phrases like 'we expect,' 'we anticipate,' and 'should be' were standard, but specific qualifiers like 'we're being prudent with our guide' and 'it feels more normalized' signaled caution about over-committing. They hedged the industrial recovery by noting 'you never know if it's long lasting,' and regarding FARO margins, they used 'we think there's a tremendous amount of synergy' rather than guaranteeing the outcome. This pattern suggests high confidence in their operational control but lower confidence in external macro factors.
We're being prudent with our guide. - Dave Zapico, Chairman and Chief Executive Officer
Pricing is not going backwards. It's gonna stick. - Dave Zapico, Chairman and Chief Executive Officer
We're feeling pretty good right now. - Dave Zapico, Chairman and Chief Executive Officer
We have a strong pipeline of deals right now. - Dave Zapico, Chairman and Chief Executive Officer
Conditions remain constructive. - Dave Zapico, Chairman and Chief Executive Officer
We're navigating through sluggish industrial markets. - Dave Zapico, Chairman and Chief Executive Officer
Analyst Sentiment: Analysts were generally inquisitive and focused on the sustainability of the growth rebound, particularly in the Electronic Instruments Group (EIG) and the Process segment. Questions from firms like D.A. Davidson, RBC, and Morgan Stanley probed the conservatism of the guidance relative to Q4 strength and the mechanics of the FARO integration. There was a tone of skepticism regarding the 'short cycle' recovery, with analysts seeking confirmation that the improvement was structural rather than a fleeting bounce.
Management Responses: Management responses were direct and detailed, particularly from CEO Dave Zapico, who articulated a clear 'two-speed' economy narrative (strong A&D/Power, weak Industrial). They were transparent about the dilutive impact of FARO but provided a specific roadmap for margin improvement (doubling EBITDA margins to 30%). They effectively deflected concerns about the conservative guide by emphasizing 'prudence' and the historical difficulty of predicting industrial cycles, while simultaneously highlighting record order intake in December and January.
EIG and Process Segment Recovery: Analysts asked repeatedly about the low organic growth (2%) in EIG and the specific drivers within the Process segment. Management explained that Process turned positive in Q4 for the first time and is expected to grow low single digits in 2026, driven by semiconductors and metals, while oil & gas and research remain weak.
FARO Acquisition and Margins: There was significant focus on the FARO deal, its current margin dilution (mid-teens vs AMETEK's 30%+), and the path to improvement. Management detailed the restructuring charges and the strategy to leverage AMETEK's operating system to double margins, though they noted it would take a couple of years.
Pricing and Tariffs: Analysts inquired about the 2026 pricing environment given past inflation and tariffs. Management confidently stated they have a 'positive price cost spread' and that pricing 'sticks' because they are in mission-critical niches, expecting to offset inflation and known tariffs again in 2026.
M&A Pipeline and Capital Deployment: Questions centered on the capacity for deals and the quality of the pipeline. Management expressed high enthusiasm, noting a 'strong pipeline' with 'larger deals' than usual and the capacity to spend over $5 billion while maintaining an investment-grade rating.
China Exposure: Analysts asked for color on the return to growth in China. Management attributed the low double-digit growth to specific niches like EV testing, nuclear power, and automation, while acknowledging broader macro issues like real estate deflation.
AMETEK presents a compelling investment case driven by its proven 'Four-Growth-Strategy' and exceptional capital allocation discipline. (1) The company has demonstrated high-quality execution, achieving record sales, EPS, and margins in 2025 despite a sluggish industrial backdrop, proving the resilience of its diversified niche portfolio. (2) Key growth drivers include a record $3.58B backlog, strong momentum in Aerospace & Defense and Power markets (data centers/grid), and a robust M&A pipeline with $5B+ deployment capacity. (3) Critical factors for success include the successful integration of FARO to unlock margin synergies and the sustainability of the recovery in the Process/Industrial end markets. (4) Investors should monitor core margin expansion (targeting 30 bps in 2026) and free cash flow conversion (guided >110%). (5) Risks include a delayed industrial recovery impacting EIG growth and the potential for tariff/inflation headwinds to pressure margins if pricing power wanes. (6) Valuation appears supported by the company's consistent double-digit ROIC and strong balance sheet (Net Debt/EBITDA 0.8x). (7) We recommend a BUY rating based on the company's ability to generate double-digit EPS growth (6-9% guide plus potential upside from conservative assumptions) while returning capital and aggressively pursuing accretive acquisitions.
The transcript suggests a tentative stabilization in the industrial sector after a prolonged downturn. Management noted that 'conditions remain constructive' and that they are seeing 'steady improvements' in their process businesses, which turned positive in Q4. This implies that the 'three years of negative PMI prints' may be ending, signaling a potential broader bottoming in industrial capital expenditure, particularly supported by an 'industrial renaissance across the West.'
There is a confirmed secular growth trend in power infrastructure driven by the data center build-out. AMETEK management explicitly cited 'global grid modernization and applications supporting the data center build out' as a key driver for their Power business. This indicates that the demand for power generation, backup power, and microgrids is a durable macro trend benefiting the broader electrical equipment ecosystem.
European defense spending is accelerating, creating a sustainable growth market for defense contractors. Management highlighted 'expanding defense spending in the region' (Europe) and noted that their European defense businesses are winning content on new air defense systems and UAV platforms. This reflects a macro shift where increased geopolitical tensions are translating into long-term budget increases for Western defense capabilities.